Agilent acquires Proscia in deal worth up to $270m
The transaction, which is expected to close in Agilent’s fiscal year 2027, follows its $950m acquisition of Biocare Medical in March 2026.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo